Focus on quality over quantity, in-house urge EPO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Focus on quality over quantity, in-house urge EPO

EPO

More than 70 people attended the Industry Patent Quality Charter roundtable today, December 8

The EPO must prioritise patent quality alongside speed of grant, in-house counsel argued at a public roundtable meeting today, December 8.

More than 70 people, including representatives from industry, law firms, and national patent offices, attended the Industry Patent Quality Charter meeting this morning.

Beat Weibel, chief intellectual property counsel at Siemens in Munich and the meeting organiser, said the EPO hadn’t listened to concerns on patent quality.

The EPO focused too much on internal efficiency and speed of grant at the expense of thorough search and examination, he said.

Richard Lloyd, director of patents at HP in France, said the EPO needed to give examiners enough time to be thorough in their work.

“Quality will come from the people the EPO has and the time they are given,” he said.

Joerg Thomaier, head of IP at Bayer in Germany, cited internal EPO correspondence that he said underlined the EPO’s focus on efficiency above quality.

An examiner who raised doubts over the patentability of an application was told to grant it anyway by the chair of his examination division, Thomaier claimed.

Sabine Kruspig, of counsel at Schwarz & Partner in Munich and an EPO examiner from 1992 to 2015, said the office viewed itself as a company with a production line.

Gabriele Mohsler, vice president of patent development at Ericsson in Cologne, was one of several in-house counsel to call for a more thorough examination of inventive step at the EPO.

“We need examiners to rigorously look into the prior art,” she said.

Time trial

Other counsel praised the EPO's work in speeding up grant times and clearing its backlog of patent applications.

Gautier Engisch, vice president and associate general counsel at Procter & Gamble in Brussels, said timeliness had once been a serious problem at the office.

“The EPO heard the complaint and fixed the problem,” he said.

Better searches and examination shouldn't come at the cost of timeliness, he added.

Lloyd of HP said the EPO search was seen as the industry gold standard. He also praised the office for its improvements on timeliness.

But he agreed that the focus should shift to quality, and that examiners should have enough time to do their jobs.

“The EPO is using new technology and trying to increase its coverage of databases, but it isn’t possible to eliminate the human element,” he said.

Cultural leadership was needed from the top to improve quality, Lloyd added.

Other suggestions included training opportunities for EPO examiners at corporate IP departments and an anonymous feedback loop for users.

Representatives from the national IP offices of San Marino, Switzerland, the UK, Hungary, Germany, Austria, Denmark, Finland, Sweden, and Croatia attended the meeting.

The EPO did not send a representative.

A spokesperson for the EPO rejected the criticisms of its internal processes by members of the industry group when contacted by Managing IP last week.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article